FILE - The Eli Lilly corporate headquarters is pictured April 26, 2017, in Indianapolis. A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day. Eli Lilly announced the results Monday, Sept. 14, 2020, from a 1,000-person study sponsored by the U.S. National Institute of Allergy and Infectious Diseases.
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day. The study tested baricitinib, a pill that Indianapolis-based Lilly already sells as Olumiant to treat rheumatoid arthritis, the less common form of arthritis that occurs when a mistaken or overreacting immune system attacks joints, causing inflammation. An overactive immune system also can lead to serious problems in coronavirus patients.
If that’s approved, Lilly will propose that the drug be sold through usual commercial means. Based on current pricing, the government would pay $105 per patient per day, and for people with private insurance, hospitals would pay about $150 per day, Lilly said. What a patient ends up paying out of pocket depends on many factors.
You would like to of thought they would of tried this drug earlier then now. 5 days is a big difference and since it is already approved for commercial use they shouldn't have an issue quickly through the red tape.
Fake news
I’ll just repeat that for the dummies. Shortens recovery by (only) 1 DAY!
The ant-inflammatory is the key in the treatment against COVID_19. It's the difference between life and death, even above the fan. 😷
^ 'All study participants received remdesivir, a Gilead Sciences drug' 29.06.2020 BUSTED: Eight NIH Coronavirus Treatment Experts Disclosed Financial Ties To Gilead - National File 1/2
Makes no sense. 1 day is within statistical error, so meaningless
Ecom companies and drug makers made Billions during COVID19 but ordinary citizens suffered big time financially.